JP Patent

JP2018507214A — Ｆｇｆｒ４阻害剤としての二環式複素環

Assigned to Incyte Corp · Expires 2018-03-15 · 8y expired

What this patent protects

本発明は、ＦＧＦＲ４酵素の阻害剤であり、癌等のＦＧＦＲ４関連疾患の治療に有用な二環式複素環及びその医薬組成物に関する。

USPTO Abstract

本発明は、ＦＧＦＲ４酵素の阻害剤であり、癌等のＦＧＦＲ４関連疾患の治療に有用な二環式複素環及びその医薬組成物に関する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2018507214A
Jurisdiction
JP
Classification
—
Expires
2018-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Incyte Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.